Trending News
News
News
New Funding for Ebola Hides an Ongoing Decline
A new report gives the first ever picture of global investment in Ebola research and development (R&D), reporting that this investment might have come at the expense of efforts to develop drugs, vaccines and diagnostics for other neglected diseases, which collectively cause more than six million deaths every year in developing countries.
News
Protein 'Talks' to Wrong Partners in Cystic Fibrosis
Scientists at The Scripps Research Institute (TSRI) have found evidence that a mutant protein responsible for most cases of cystic fibrosis is so busy “talking” to the wrong cellular neighbors that it cannot function normally and is prematurely degraded.
News
Gene Pair Plays Crucial Role in Colon Cancer
In a new study researchers from the University of Pennsylvania describe two related genes in the Musashi family that are required for colon cancer to develop, and that may be useful targets for effective treatment.
News
Cytos Biotechnology, Kuros Biosurgery Combine
Combined company aims to be a leader in the field of tissue repair and regeneration.
News
TxCell Signs Strategic Agreement with MaSTherCell
Agreement for European manufacturing of its cell therapy products.
News
Rondo AG Merges US-subsidiary Rondo-Pak with CGS
Rondo-Pak will offer a comprehensive portfolio of packaging and printed components.
News
Mitochondria Affect Stress Responses
Cell's powerhouse plays role in mind-body interactions, with long-term health effects.
News
Pelago, AstraZeneca Collaborate
Research collaboration and license agreement on the CETSA® method.
News
GSK, Zymeworks Collaborate
Focus on the research, development, and commercialization of novel Fc-engineered monoclonal and bi-specific antibody therapeutics which have been optimized for specific therapeutic effects.
News
Cancer-causing Protein “Turned Off”
Clinical trials on the horizon for experimental cancer drug.
Advertisement